Tumor suppression by Ink4a-Arf: Progress and puzzles

Current Opinion in Genetics and Development

Volumn 13, Issue 1, 2003, Pages 77-83

  Lowe, Scott W ^a   Sherr, Charles J ^b  

^a Simons Center for Quantitative Biology   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GENE PRODUCT; PROTEIN P16; PROTEIN P19; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER CELL; CANCER INHIBITION; CELL AGING; CELL PROLIFERATION; DRUG RESPONSE; FEEDBACK SYSTEM; GENE LOCUS; INK4A ARF GENE; LYMPHOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 0037309326     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(02)00013-8     Document Type: Review

References (53)

1. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell. Biol. 2:2001;731-737.
2. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1571-1583.
3. Kip1 plays a positive role in enabling cell-cycle progression.
4. Shay J.W., Wright W.E. When do telomeres matter? Science. 291:2001;839-840.
5. Jacobs J.J.L., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:1999;164-168.
6. Bird J.J., Brown D.R., Mullen A.C., Moskowitz N.H., Mahowald M.A., Sider J.R., Gajewski T.F., Wang C.-R., Reiner S.L. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:1998;229-237.
7. ••].
8. ••] describe animals lacking Ink4a and retaining Arf function, thereby helping to resolve long-standing debates about the relative contributions of these genes to cell-cycle control, cell immortalization, and tumorigenesis in vivo.
9. ••].
10. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88.
11. ARF act in overlapping pathways in cellular immortalization. Nat. Cell. Biol. 2:2000;148-155.
12. Ink4a loss on senescence of murine bone marrow-derived pre-B cells and macrophages. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9654-9659 Some Arf-null primary mouse cells appear to be immortal in cell culture, whereas others must silence Ink4a to become established as permanent cell lines. Therefore, the relative contribution of Arf and Ink4a mutations to immortalization is not strictly species-specific, but is also cell-type dependent.
13. Holland E.C., Hively W.P., Gallo V., Varmus H.E. Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of Ink4a-Arf induces hyperploidy in cultured mouse astrocytes. Genes Dev. 12:1998;3644-3649.
14. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:1997;649-659.
15. Lin A.W., Lowe S.W. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5025-5030.
16. Hahn W.C., Weinberg R.A. Modeling the molecular circuitry of cancer. Nat. Rev. Cancer. 2:2002;331-341.
17. Wright W.E., Shay J.W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat. Med. 6:2000;849-851.
18. Smogorzewska A., De Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348 Acute activation of telomere dysfunction using dominant-negative TRF2, a telomere-binding protein, leads to differential dependencies on Ink4a-Rb in human and mouse cells. Cell-cycle arrest in mouse fibroblasts in response to telomere dysfunction appears to depend exclusively on the Arf-p53 axis, whereas both the Arf-p53 and Ink4a-Rb checkpoints are activated in human cells.
19. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:2000;573-574.
20. Sherr C.J., DePinho R.A. Cellular senescence: mitotic clock or culture shock. Cell. 102:2001;407-410.
21. •].
22. •].
23. •] provide data supporting the hypothesis that conditions of the tissue culture environment (i.e. 'culture shock' [20]) determine the rate of induction of Ink4a and Arf in regulating cellular senescence. The studies indirectly support the view that senescence is a general response to stress rather than a process strictly linked to replicative aging.
24. Passegue E., Wagner E.F. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19:2000;2969-2979.
25. •].
26. •] reveal that Ets and Id1 have opposing effects in up- and down-regulating Ink4a gene expression, respectively.
27. ARF/p53-induced proliferative arrest. Cancer Cell. 2:2002;55-65 Arf is induced by E2F, but Rb-E2F function is required for Arf-induced arrest. Hence Rb-E2F acts both upstream and downstream of Arf-p53. The results are consistent with previously described effects on Arf-p53 signaling observed in MEFs lacking all Rb-family proteins [34,35].
28. Maestro R., Dei Tos A.P., Hamamori Y., Krasnokutsky S., Sartorelli V., Kedes L., Doglioni C., Beach D., Hannon G.J. twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13:1999;2207-2217.
29. ARF) and is amplified in a subset of human breast cancers. Nat. Genet. 26:2000;291-299.
30. ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
31. 1 checkpoint is required for E2F-induced S-phase entry. Nat. Genet. 31:2002;190-194 Established cell lines can be induced to enter S phase by E2F but the integrity of the Arf-p53 and Rb checkpoints prevents E2F-induced cell-cycle progression in primary diploid cells. Therefore, the process of establishment of human cell lines requires disruption of the Rb-p53 network.
32. •].
33. •] describe a feed-forward transcriptional control mechanism that insulates target genes from non-sustained signals. Regulation of the Ink4a-Arf locus may involve similar principles.
34. Dannenberg J.-H., van Rossum A., Schuijff L., te Riele H. Ablation of the retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14:2000;3051-3064.
35. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization. Genes Dev. 14:2000;3037-3050.
36. Bardeesy N., Bastian B.C., Hezel A., Pinkel D., DePinho R.A., Chin L. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol. Cell. Biol. 21:2001;2144-2153.
37. Ink4a and p53 collaborate to induce cytostasis triggered by cytotoxic drug therapy. Hence, Ink4a and Arf regulate distinct functions in vivo, with drug-induced cytostasis mimicking a senescence response.
38. Pantoja C., Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene. 18:1999;4974-4982.
39. Modestou M., Puig-Antich V., Korgaonkar C., Eapen A., Quelle D.E. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways. Cancer Res. 61:2001;3145-3150.
40. Coats S., Whyte P., Fero M.L., Lacy S., Chung G., Randel E., Firpo E., Roberts J.M. A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells. Curr. Biol. 9:1999;163-173.
41. Cip1 is required for Arf-induced cell-cycle arrest.
42. Weber J.D., Jeffers J.R., Rehg J.E., Randle D.H., Lozano G., Roussel M.F., Sherr C.J., Zambetti G.P. p53-independent functions of the p19ARF tumor suppressor. Genes Dev. 14:2000;2358-2365.
43. Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M., McCormick F. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell. 103:2000;321-330.
44. Arf. This reinforces previous conclusions [43] that Ras can both positively and negatively regulate Arf function.
45. McKeller R.N., Fowler J.L., Cunningham J.J., Warner N., Smeyne R.J., Zindy F., Skapek S.X. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3848-3853 Arf regulates vascular regression in vivo independently of p53. This is the first paper to define an essential role for Arf during mouse development.
46. Bachoo R.M., Maher E.A., Ligon K.L., Sharpless N.E., Chan S.S., You M.J., Tang Y., DeFrances J., Stover E., Weissleder R.et al. Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 1:2002;269-277.
47. Sharpless N.E., Alson S., Chan S., Silver D.P., Castrillon D.H., DePinho R.A. p16(INK4a) and p53 deficiency cooperate in tumorigenesis. Cancer Res. 62:2002;2761-2765.
48. You M.J., Castrillon D.H., Bastian B.C., O'Hagan R.C., Bosenberg M.W., Parsons R., Chin L., DePinho R.A. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 99:2002;1455-1460.
49. Lund A.H., Turner G., Trubetskoy A., Verhoeven E., Wientjens E., Hulsman D., Russell R., DePinho R.A., Lenz J., van Lohuizen M. Genome-wide retroviral insertional tagging of genes involved in cancer in CDkn2a-deficient mice. Nat. Genet. 32:2002;160-165 A genetic screen in vivo pinpoints a series of genes that accelerate cancer in Ink4a-Arf-deficient mice.
50. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:1999;2658-2669.
51. Jacobs J.J.L., Scheijen B., Vonchen J.-W., Kieboom K., Berns A., van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13:1999;2678-2690.
52. Schmitt C.A., McCurrach M.E., De Stanchina E., Lowe S.W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:1999;2670-2677.
53. Schmitt C.A., Fridman J.S., Yang M., Baranov E., Hoffman R.M., Lowe S.W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell. 1:2002;289-298.